Find similar content

Source channel @githubtrending · Post #15066 · Aug 16

#python#agents#ai#api_gateway#asyncio#authentication_middleware#devops#docker#fastapi#federation#gateway#generative_ai#jwt#kubernetes#llm_agents#mcp#model_context_protocol#observability#prompt_engineering#python#tools The MCP Gateway is a powerful tool that unifies different AI service protocols like REST and MCP into one easy-to-use endpoint. It helps you manage multiple AI tools and services securely with features like authentication, retries, rate-limiting, and real-time monitoring through an admin UI. You can run it locally or in scalable cloud environments using Docker or Kubernetes. It supports various communication methods (HTTP, WebSocket, SSE, stdio) and offers observability with OpenTelemetry for tracking AI tool usage and performance. This gateway simplifies connecting AI clients to diverse services, making development and management more efficient and secure. https://github.com/IBM/mcp-context-forge

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment